CH661443A5 - Pharmaceutical compositions having metabolic activity - Google Patents

Pharmaceutical compositions having metabolic activity Download PDF

Info

Publication number
CH661443A5
CH661443A5 CH5572/84A CH557284A CH661443A5 CH 661443 A5 CH661443 A5 CH 661443A5 CH 5572/84 A CH5572/84 A CH 5572/84A CH 557284 A CH557284 A CH 557284A CH 661443 A5 CH661443 A5 CH 661443A5
Authority
CH
Switzerland
Prior art keywords
coenzyme
panax
pharmaceutical compositions
association
tests
Prior art date
Application number
CH5572/84A
Other languages
English (en)
Italian (it)
Inventor
Stefania Meola
Original Assignee
Seuref Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref Ag filed Critical Seuref Ag
Priority to CH5572/84A priority Critical patent/CH661443A5/it
Priority to IT8522935A priority patent/IT1214641B/it
Priority to DE19863609005 priority patent/DE3609005A1/de
Priority to FR868604853A priority patent/FR2596650B1/fr
Priority to JP61107522A priority patent/JPS62263130A/ja
Publication of CH661443A5 publication Critical patent/CH661443A5/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Botany (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH5572/84A 1984-11-22 1984-11-22 Pharmaceutical compositions having metabolic activity CH661443A5 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CH5572/84A CH661443A5 (en) 1984-11-22 1984-11-22 Pharmaceutical compositions having metabolic activity
IT8522935A IT1214641B (it) 1984-11-22 1985-11-21 Composizioni farmaceutiche ad azione antianossica e metabolica cerebrale.
DE19863609005 DE3609005A1 (de) 1984-11-22 1986-03-18 Pharmazeutische zusammensetzungen mit metabolischer aktivitaet
FR868604853A FR2596650B1 (fr) 1984-11-22 1986-04-04 Compositions pharmaceutiques a activite metabolique comportant un coenzyme ubiquinonique et un extrait de panax
JP61107522A JPS62263130A (ja) 1984-11-22 1986-05-10 新陳代謝活性を有する薬学的組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH5572/84A CH661443A5 (en) 1984-11-22 1984-11-22 Pharmaceutical compositions having metabolic activity
DE19863609005 DE3609005A1 (de) 1984-11-22 1986-03-18 Pharmazeutische zusammensetzungen mit metabolischer aktivitaet

Publications (1)

Publication Number Publication Date
CH661443A5 true CH661443A5 (en) 1987-07-31

Family

ID=37877036

Family Applications (1)

Application Number Title Priority Date Filing Date
CH5572/84A CH661443A5 (en) 1984-11-22 1984-11-22 Pharmaceutical compositions having metabolic activity

Country Status (5)

Country Link
JP (1) JPS62263130A (fr)
CH (1) CH661443A5 (fr)
DE (1) DE3609005A1 (fr)
FR (1) FR2596650B1 (fr)
IT (1) IT1214641B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3515140B2 (ja) * 1993-04-02 2004-04-05 出光石油化学株式会社 ブロイラー用腹水症防止剤及び腹水症防止方法
US5951998A (en) * 1997-02-18 1999-09-14 Idemitsu Materials Co., Ltd. Ascites-preventive agent and ascites-preventive method for broilers
TWI222357B (en) 2000-01-11 2004-10-21 Medical & Pharm Ind Tech & Dev Anti-ulcer pharmaceutical composition and the preparation and use thereof
JP2004155778A (ja) * 2002-10-16 2004-06-03 Taisho Pharmaceut Co Ltd ユビキノン含有滋養強壮剤
TW200812601A (en) * 2006-05-30 2008-03-16 Kowa Co Medicine for recovering from fatigue
US9314493B2 (en) 2007-05-28 2016-04-19 Amorepacific Corporation Method for treating vascular inflammation, improving skin beauty and improving male sexual function using ginseng berry
KR101614110B1 (ko) 2008-11-28 2016-04-21 (주)아모레퍼시픽 동맥경화 예방 또는 치료용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5626818A (en) * 1979-08-13 1981-03-16 Osaka Chem Lab Glucocorticoid drug
JPS5910511A (ja) * 1982-07-07 1984-01-20 Eisai Co Ltd 脂溶性物質含有水性液
CH661438A5 (it) * 1984-04-09 1987-07-31 Seuref Ag Composizioni farmaceutiche ad azione antianossica e metabolica cerebrale.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum

Also Published As

Publication number Publication date
FR2596650B1 (fr) 1991-09-13
IT1214641B (it) 1990-01-18
DE3609005A1 (de) 1987-09-24
FR2596650A1 (fr) 1987-10-09
IT8522935A0 (it) 1985-11-21
JPS62263130A (ja) 1987-11-16

Similar Documents

Publication Publication Date Title
DE69834658T2 (de) Verwendung von aminothiolverbindungen zur behandlung von nerven- und nieren-erkrankungen und der arzneimitteltoxizität
JP4166951B2 (ja) 脳性および加齢性疾患の予防または治療のためのカルニチンおよびレスベラトロールの組み合わせ
AT501681A1 (de) Organische verbindungen
DE60015893T2 (de) Zusammensetzung enthaltend ein carnitine und glutathion, zur erhöhung der absorption von glutathion und zur synergisierung seiner effekte
JPH07509230A (ja) クレアチン供給デポーの増加法
BRPI0710405B1 (pt) comprimido de racecadotril, processo de preparação de um comprimido de racecadotril e uso de racecadotril
KR20100124248A (ko) 은행나무 잎으로 만든 추출물의 용도
US20140112983A1 (en) Nitrite compositions and uses thereof
EP0661051A2 (fr) Médicament pour le traitement des altérations de la perfusion
CH661443A5 (en) Pharmaceutical compositions having metabolic activity
CN108567775B (zh) 硫辛酸在制备治疗压力负荷性心肌损伤的药物组合物中的应用
TW200812594A (en) Medicine for prevention of and/or recovery from fatigue
DE69007065T2 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
JPH07330593A (ja) 疲労改善剤
DE3035494A1 (de) Carnitin enthaltendes arzneimittel zur behandlung von hyperlipidaemie und hyperlipoproteinaemie, sowie verwendung von carnitin zur herstellung eines solchen arzneimittels
DE2743704C2 (de) L- oder DL-Phenylglycine enthaltende Arzneimittel
DE102004038155A1 (de) Physiologisch verträgliche Zusammensetzung enthaltend alpha-Liponsäure, Kreatin und ein Phospholipid
Li et al. Sub-chronic safety evaluation of the ethanol extract of Aralia elata leaves in Beagle dogs
AT412381B (de) Kombinations-präparat, enthaltend mineralstoffe, vitamine, kohlenhydrate und aminosäuren
EP0471388A2 (fr) Médicament pour le traitement de l'insuffisance cardiaque
CN102309480B (zh) 一种复方降压药物组合物及其制备方法
KR100256867B1 (ko) 엘-무스콘의 의약용도
ITFI20090073A1 (it) Acido alfa-lipoico a rilascio prolungato.
US20080095865A1 (en) Composition and method for increasing lean muscle mass, decreasing muscle loss, increasing muscle strength and improving athletic performance
US11666593B2 (en) Compositions containing adenosine triphosphate (ATP) and methods of use

Legal Events

Date Code Title Description
PUE Assignment

Owner name: SEUREF AG TRANSFER- SIGMA-TAU HEALTHSCIENCE S.P.A.

PL Patent ceased